nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Asthenia—Sunitinib—pancreatic cancer	0.000611	0.000835	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—pancreatic cancer	0.00061	0.000834	CcSEcCtD
Naratriptan—Arrhythmia—Docetaxel—pancreatic cancer	0.00061	0.000833	CcSEcCtD
Naratriptan—Dyspnoea—Gemcitabine—pancreatic cancer	0.000609	0.000832	CcSEcCtD
Naratriptan—Somnolence—Gemcitabine—pancreatic cancer	0.000608	0.00083	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—pancreatic cancer	0.000606	0.000828	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000606	0.000828	CcSEcCtD
Naratriptan—Fatigue—Irinotecan—pancreatic cancer	0.000605	0.000826	CcSEcCtD
Naratriptan—Paraesthesia—Fluorouracil—pancreatic cancer	0.000603	0.000824	CcSEcCtD
Naratriptan—Alopecia—Docetaxel—pancreatic cancer	0.000603	0.000824	CcSEcCtD
Naratriptan—Pruritus—Sunitinib—pancreatic cancer	0.000603	0.000823	CcSEcCtD
Naratriptan—Pain—Irinotecan—pancreatic cancer	0.0006	0.00082	CcSEcCtD
Naratriptan—Constipation—Irinotecan—pancreatic cancer	0.0006	0.00082	CcSEcCtD
Naratriptan—Dyspnoea—Fluorouracil—pancreatic cancer	0.000599	0.000818	CcSEcCtD
Naratriptan—Somnolence—Fluorouracil—pancreatic cancer	0.000597	0.000816	CcSEcCtD
Naratriptan—Erythema—Docetaxel—pancreatic cancer	0.000594	0.000812	CcSEcCtD
Naratriptan—Nausea—Tamoxifen—pancreatic cancer	0.000591	0.000807	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00059	0.000806	CcSEcCtD
Naratriptan—Fatigue—Gemcitabine—pancreatic cancer	0.000589	0.000805	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—pancreatic cancer	0.000589	0.000805	CcSEcCtD
Naratriptan—Pain—Gemcitabine—pancreatic cancer	0.000584	0.000798	CcSEcCtD
Naratriptan—Constipation—Gemcitabine—pancreatic cancer	0.000584	0.000798	CcSEcCtD
Naratriptan—Nausea—Erlotinib—pancreatic cancer	0.000584	0.000798	CcSEcCtD
Naratriptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000583	0.000796	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00058	0.000793	CcSEcCtD
Naratriptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.000578	0.00079	CcSEcCtD
Naratriptan—Asthma—Epirubicin—pancreatic cancer	0.000575	0.000786	CcSEcCtD
Naratriptan—Pain—Fluorouracil—pancreatic cancer	0.000575	0.000785	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—pancreatic cancer	0.000573	0.000782	CcSEcCtD
Naratriptan—Muscle spasms—Docetaxel—pancreatic cancer	0.000571	0.000781	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000569	0.000777	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—pancreatic cancer	0.000565	0.000771	CcSEcCtD
Naratriptan—Dizziness—Sunitinib—pancreatic cancer	0.000563	0.00077	CcSEcCtD
Naratriptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000563	0.000769	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—pancreatic cancer	0.00056	0.000766	CcSEcCtD
Naratriptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000555	0.000758	CcSEcCtD
Naratriptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000554	0.000757	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—pancreatic cancer	0.000553	0.000756	CcSEcCtD
Naratriptan—Anaemia—Docetaxel—pancreatic cancer	0.000549	0.00075	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—pancreatic cancer	0.000545	0.000745	CcSEcCtD
Naratriptan—Vomiting—Sunitinib—pancreatic cancer	0.000542	0.00074	CcSEcCtD
Naratriptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.00054	0.000738	CcSEcCtD
Naratriptan—Rash—Sunitinib—pancreatic cancer	0.000537	0.000734	CcSEcCtD
Naratriptan—Dermatitis—Sunitinib—pancreatic cancer	0.000537	0.000733	CcSEcCtD
Naratriptan—Urticaria—Fluorouracil—pancreatic cancer	0.000534	0.000729	CcSEcCtD
Naratriptan—Headache—Sunitinib—pancreatic cancer	0.000534	0.000729	CcSEcCtD
Naratriptan—Syncope—Docetaxel—pancreatic cancer	0.000533	0.000728	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—pancreatic cancer	0.000532	0.000727	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—pancreatic cancer	0.000531	0.000726	CcSEcCtD
Naratriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000531	0.000726	CcSEcCtD
Naratriptan—Palpitations—Docetaxel—pancreatic cancer	0.000525	0.000717	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000525	0.000717	CcSEcCtD
Naratriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000522	0.000714	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000519	0.000709	CcSEcCtD
Naratriptan—Cough—Docetaxel—pancreatic cancer	0.000519	0.000708	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—pancreatic cancer	0.000519	0.000708	CcSEcCtD
Naratriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000517	0.000706	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—pancreatic cancer	0.000516	0.000705	CcSEcCtD
Naratriptan—Convulsion—Docetaxel—pancreatic cancer	0.000515	0.000703	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—pancreatic cancer	0.000513	0.000701	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—pancreatic cancer	0.000512	0.000699	CcSEcCtD
Naratriptan—Myalgia—Docetaxel—pancreatic cancer	0.000506	0.000691	CcSEcCtD
Naratriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000506	0.000691	CcSEcCtD
Naratriptan—Nausea—Sunitinib—pancreatic cancer	0.000506	0.000691	CcSEcCtD
Naratriptan—Asthenia—Irinotecan—pancreatic cancer	0.000503	0.000688	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000503	0.000687	CcSEcCtD
Naratriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000495	0.000676	CcSEcCtD
Naratriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000495	0.000676	CcSEcCtD
Naratriptan—Sweating—Epirubicin—pancreatic cancer	0.000492	0.000672	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000492	0.000672	CcSEcCtD
Naratriptan—Asthenia—Gemcitabine—pancreatic cancer	0.00049	0.00067	CcSEcCtD
Naratriptan—Confusional state—Docetaxel—pancreatic cancer	0.000489	0.000668	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000486	0.000664	CcSEcCtD
Naratriptan—Oedema—Docetaxel—pancreatic cancer	0.000485	0.000663	CcSEcCtD
Naratriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000485	0.000663	CcSEcCtD
Naratriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000484	0.000661	CcSEcCtD
Naratriptan—Infection—Docetaxel—pancreatic cancer	0.000482	0.000658	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—pancreatic cancer	0.000481	0.000657	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00048	0.000656	CcSEcCtD
Naratriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.00048	0.000656	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—pancreatic cancer	0.000477	0.000652	CcSEcCtD
Naratriptan—Shock—Docetaxel—pancreatic cancer	0.000477	0.000652	CcSEcCtD
Naratriptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000476	0.00065	CcSEcCtD
Naratriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000475	0.00065	CcSEcCtD
Naratriptan—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000475	0.000649	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—pancreatic cancer	0.000475	0.000648	CcSEcCtD
Naratriptan—Skin disorder—Docetaxel—pancreatic cancer	0.000471	0.000644	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—pancreatic cancer	0.000469	0.00064	CcSEcCtD
Naratriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000468	0.000639	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000465	0.000636	CcSEcCtD
Naratriptan—Dizziness—Irinotecan—pancreatic cancer	0.000464	0.000634	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—pancreatic cancer	0.000463	0.000632	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—pancreatic cancer	0.000461	0.000629	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.00046	0.000628	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000458	0.000626	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—pancreatic cancer	0.000455	0.000622	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—pancreatic cancer	0.000453	0.000619	CcSEcCtD
Naratriptan—Vomiting—Irinotecan—pancreatic cancer	0.000446	0.000609	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—pancreatic cancer	0.000445	0.000608	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—pancreatic cancer	0.000444	0.000607	CcSEcCtD
Naratriptan—Rash—Irinotecan—pancreatic cancer	0.000442	0.000604	CcSEcCtD
Naratriptan—Dermatitis—Irinotecan—pancreatic cancer	0.000442	0.000604	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000442	0.000604	CcSEcCtD
Naratriptan—Headache—Irinotecan—pancreatic cancer	0.00044	0.0006	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—pancreatic cancer	0.000436	0.000595	CcSEcCtD
Naratriptan—Vomiting—Gemcitabine—pancreatic cancer	0.000435	0.000594	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—pancreatic cancer	0.000434	0.000593	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—pancreatic cancer	0.000432	0.000591	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—pancreatic cancer	0.000431	0.000589	CcSEcCtD
Naratriptan—Rash—Gemcitabine—pancreatic cancer	0.000431	0.000589	CcSEcCtD
Naratriptan—Dermatitis—Gemcitabine—pancreatic cancer	0.000431	0.000588	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—pancreatic cancer	0.000429	0.000587	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—pancreatic cancer	0.000428	0.000585	CcSEcCtD
Naratriptan—Headache—Gemcitabine—pancreatic cancer	0.000428	0.000585	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—pancreatic cancer	0.000427	0.000584	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—pancreatic cancer	0.000427	0.000584	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—pancreatic cancer	0.000426	0.000582	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000424	0.000579	CcSEcCtD
Naratriptan—Rash—Fluorouracil—pancreatic cancer	0.000424	0.000579	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—pancreatic cancer	0.000423	0.000578	CcSEcCtD
Naratriptan—Headache—Fluorouracil—pancreatic cancer	0.000421	0.000575	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000419	0.000572	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—pancreatic cancer	0.000418	0.000571	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—pancreatic cancer	0.000418	0.000571	CcSEcCtD
Naratriptan—Nausea—Irinotecan—pancreatic cancer	0.000417	0.000569	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—pancreatic cancer	0.000416	0.000568	CcSEcCtD
Naratriptan—Pain—Docetaxel—pancreatic cancer	0.000415	0.000567	CcSEcCtD
Naratriptan—Constipation—Docetaxel—pancreatic cancer	0.000415	0.000567	CcSEcCtD
Naratriptan—Chills—Epirubicin—pancreatic cancer	0.000413	0.000564	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—pancreatic cancer	0.000411	0.000562	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—pancreatic cancer	0.000407	0.000556	CcSEcCtD
Naratriptan—Nausea—Gemcitabine—pancreatic cancer	0.000406	0.000555	CcSEcCtD
Naratriptan—Erythema—Epirubicin—pancreatic cancer	0.000401	0.000548	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.0004	0.000546	CcSEcCtD
Naratriptan—Nausea—Fluorouracil—pancreatic cancer	0.000399	0.000545	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—pancreatic cancer	0.000397	0.000543	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000395	0.00054	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—pancreatic cancer	0.000387	0.000528	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—pancreatic cancer	0.000385	0.000527	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—pancreatic cancer	0.000385	0.000526	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000383	0.000524	CcSEcCtD
Naratriptan—Chills—Doxorubicin—pancreatic cancer	0.000382	0.000522	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—pancreatic cancer	0.000381	0.00052	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—pancreatic cancer	0.000378	0.000516	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—pancreatic cancer	0.000377	0.000514	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000372	0.000508	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—pancreatic cancer	0.000371	0.000507	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—pancreatic cancer	0.000371	0.000506	CcSEcCtD
Naratriptan—Agitation—Epirubicin—pancreatic cancer	0.000368	0.000503	CcSEcCtD
Naratriptan—Malaise—Epirubicin—pancreatic cancer	0.000362	0.000494	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—pancreatic cancer	0.00036	0.000492	CcSEcCtD
Naratriptan—Syncope—Epirubicin—pancreatic cancer	0.000359	0.000491	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000357	0.000488	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—pancreatic cancer	0.000357	0.000487	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—pancreatic cancer	0.000354	0.000484	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.000352	0.000481	CcSEcCtD
Naratriptan—Cough—Epirubicin—pancreatic cancer	0.00035	0.000478	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—pancreatic cancer	0.00035	0.000478	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—pancreatic cancer	0.000348	0.000475	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—pancreatic cancer	0.000347	0.000474	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000344	0.00047	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—pancreatic cancer	0.000343	0.000469	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—pancreatic cancer	0.000343	0.000468	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—pancreatic cancer	0.000341	0.000466	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—pancreatic cancer	0.000341	0.000466	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—pancreatic cancer	0.000341	0.000466	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—pancreatic cancer	0.00034	0.000465	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—pancreatic cancer	0.000337	0.000461	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—pancreatic cancer	0.000334	0.000457	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—pancreatic cancer	0.000334	0.000456	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—pancreatic cancer	0.000333	0.000455	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—pancreatic cancer	0.000333	0.000454	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000332	0.000453	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—pancreatic cancer	0.00033	0.000451	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—pancreatic cancer	0.000328	0.000448	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000327	0.000447	CcSEcCtD
Naratriptan—Oedema—Epirubicin—pancreatic cancer	0.000327	0.000447	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000326	0.000445	CcSEcCtD
Naratriptan—Infection—Epirubicin—pancreatic cancer	0.000325	0.000444	CcSEcCtD
Naratriptan—Cough—Doxorubicin—pancreatic cancer	0.000324	0.000442	CcSEcCtD
Naratriptan—Shock—Epirubicin—pancreatic cancer	0.000322	0.00044	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—pancreatic cancer	0.000321	0.000439	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.000321	0.000438	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—pancreatic cancer	0.000321	0.000438	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00032	0.000438	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—pancreatic cancer	0.000318	0.000434	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000316	0.000432	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—pancreatic cancer	0.000316	0.000431	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—pancreatic cancer	0.000316	0.000431	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—pancreatic cancer	0.000315	0.00043	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—pancreatic cancer	0.000312	0.000426	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000309	0.000422	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—pancreatic cancer	0.000308	0.000421	CcSEcCtD
Naratriptan—Rash—Docetaxel—pancreatic cancer	0.000306	0.000418	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—pancreatic cancer	0.000306	0.000418	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—pancreatic cancer	0.000306	0.000417	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—pancreatic cancer	0.000305	0.000417	CcSEcCtD
Naratriptan—Headache—Docetaxel—pancreatic cancer	0.000304	0.000415	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—pancreatic cancer	0.000303	0.000414	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000303	0.000414	CcSEcCtD
Naratriptan—Infection—Doxorubicin—pancreatic cancer	0.000301	0.000411	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000298	0.000407	CcSEcCtD
Naratriptan—Shock—Doxorubicin—pancreatic cancer	0.000298	0.000407	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000297	0.000406	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000296	0.000405	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—pancreatic cancer	0.000294	0.000402	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—pancreatic cancer	0.000294	0.000401	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000293	0.0004	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—pancreatic cancer	0.000292	0.000398	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—pancreatic cancer	0.000291	0.000397	CcSEcCtD
Naratriptan—Nausea—Docetaxel—pancreatic cancer	0.000288	0.000394	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—pancreatic cancer	0.000283	0.000386	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000282	0.000386	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—pancreatic cancer	0.000282	0.000385	CcSEcCtD
Naratriptan—Constipation—Epirubicin—pancreatic cancer	0.00028	0.000382	CcSEcCtD
Naratriptan—Pain—Epirubicin—pancreatic cancer	0.00028	0.000382	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000276	0.000377	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—pancreatic cancer	0.000272	0.000371	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—pancreatic cancer	0.00027	0.000369	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.00027	0.000368	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—pancreatic cancer	0.000269	0.000368	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000261	0.000357	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—pancreatic cancer	0.000261	0.000357	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—pancreatic cancer	0.00026	0.000355	CcSEcCtD
Naratriptan—Pain—Doxorubicin—pancreatic cancer	0.000259	0.000354	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—pancreatic cancer	0.000259	0.000354	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000259	0.000353	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000249	0.000341	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000241	0.000329	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—pancreatic cancer	0.00024	0.000329	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000239	0.000327	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—pancreatic cancer	0.000235	0.000321	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—pancreatic cancer	0.000231	0.000316	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—pancreatic cancer	0.000224	0.000306	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000223	0.000305	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—pancreatic cancer	0.000217	0.000297	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—pancreatic cancer	0.000216	0.000296	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—pancreatic cancer	0.000214	0.000293	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—pancreatic cancer	0.000208	0.000284	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000207	0.000283	CcSEcCtD
Naratriptan—Rash—Epirubicin—pancreatic cancer	0.000206	0.000282	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—pancreatic cancer	0.000206	0.000282	CcSEcCtD
Naratriptan—Headache—Epirubicin—pancreatic cancer	0.000205	0.00028	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—pancreatic cancer	0.0002	0.000273	CcSEcCtD
Naratriptan—Nausea—Epirubicin—pancreatic cancer	0.000194	0.000265	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—pancreatic cancer	0.000192	0.000263	CcSEcCtD
Naratriptan—Rash—Doxorubicin—pancreatic cancer	0.000191	0.000261	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—pancreatic cancer	0.000191	0.000261	CcSEcCtD
Naratriptan—Headache—Doxorubicin—pancreatic cancer	0.00019	0.000259	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—pancreatic cancer	0.00018	0.000246	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00014	0.000524	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000138	0.000517	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000137	0.000513	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000137	0.000513	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SHH—pancreatic cancer	0.000137	0.000511	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SMAD4—pancreatic cancer	0.000136	0.000509	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH4—pancreatic cancer	0.000136	0.000508	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IAPP—pancreatic cancer	0.000135	0.000505	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000135	0.000503	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SHH—pancreatic cancer	0.000134	0.000501	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GCG—pancreatic cancer	0.000134	0.000499	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH4—pancreatic cancer	0.000133	0.000497	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HES1—pancreatic cancer	0.000133	0.000497	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IAPP—pancreatic cancer	0.000132	0.000494	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HEY2—pancreatic cancer	0.000132	0.000494	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTHLH—pancreatic cancer	0.00013	0.000485	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTCH1—pancreatic cancer	0.00013	0.000485	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAST—pancreatic cancer	0.000129	0.000482	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000128	0.000476	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000127	0.000476	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTHLH—pancreatic cancer	0.000127	0.000475	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTCH1—pancreatic cancer	0.000127	0.000475	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SCT—pancreatic cancer	0.000123	0.000457	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000123	0.000457	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL8—pancreatic cancer	0.000122	0.000457	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SST—pancreatic cancer	0.000119	0.000443	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000117	0.000437	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCK—pancreatic cancer	0.000117	0.000436	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TERT—pancreatic cancer	0.000117	0.000435	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SST—pancreatic cancer	0.000116	0.000434	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JAG1—pancreatic cancer	0.000116	0.000434	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CD44—pancreatic cancer	0.000116	0.000432	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH3—pancreatic cancer	0.000116	0.000432	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000115	0.000428	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000114	0.000425	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000114	0.000425	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000114	0.000425	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JAG1—pancreatic cancer	0.000114	0.000425	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000113	0.000423	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—HRAS—pancreatic cancer	0.000113	0.000422	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000112	0.000418	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HIF1A—pancreatic cancer	0.000112	0.000416	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TSC2—pancreatic cancer	0.000111	0.000415	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GCG—pancreatic cancer	0.000111	0.000415	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR1—pancreatic cancer	0.00011	0.000409	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—pancreatic cancer	0.000109	0.000406	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000109	0.000406	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR1—pancreatic cancer	0.000107	0.000401	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000107	0.0004	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KDR—pancreatic cancer	0.000107	0.000398	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000106	0.000397	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GCG—pancreatic cancer	0.000106	0.000395	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—STK11—pancreatic cancer	0.000104	0.00039	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000104	0.000389	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GCG—pancreatic cancer	0.000104	0.000387	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000103	0.000384	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SHH—pancreatic cancer	0.000102	0.000381	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000102	0.000379	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFKBIA—pancreatic cancer	0.000101	0.000379	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGTR1—pancreatic cancer	0.000101	0.000377	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	0.000101	0.000377	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000101	0.000376	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOTCH1—pancreatic cancer	0.0001	0.000375	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STK11—pancreatic cancer	9.95e-05	0.000371	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGTR1—pancreatic cancer	9.89e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CG—pancreatic cancer	9.83e-05	0.000367	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—NRAS—pancreatic cancer	9.83e-05	0.000367	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STK11—pancreatic cancer	9.75e-05	0.000364	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGF—pancreatic cancer	9.71e-05	0.000362	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	9.69e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	9.69e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CD—pancreatic cancer	9.35e-05	0.000349	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	9.16e-05	0.000342	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TYMS—pancreatic cancer	8.99e-05	0.000335	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.98e-05	0.000335	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EGFR—pancreatic cancer	8.95e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SST—pancreatic cancer	8.86e-05	0.000331	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.79e-05	0.000328	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.74e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SMAD4—pancreatic cancer	8.72e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	8.67e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CD—pancreatic cancer	8.64e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	8.63e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—pancreatic cancer	8.63e-05	0.000322	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.56e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	8.54e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HES1—pancreatic cancer	8.51e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—KRAS—pancreatic cancer	8.46e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	8.45e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HES1—pancreatic cancer	8.34e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	8.18e-05	0.000305	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CB—pancreatic cancer	8.15e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	7.98e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	7.94e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GCG—pancreatic cancer	7.9e-05	0.000295	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—pancreatic cancer	7.83e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CA—pancreatic cancer	7.77e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.68e-05	0.000287	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	7.67e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	7.53e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CB—pancreatic cancer	7.53e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	7.46e-05	0.000278	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STK11—pancreatic cancer	7.42e-05	0.000277	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—pancreatic cancer	7.31e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	7.3e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—pancreatic cancer	7.24e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRAS—pancreatic cancer	7.19e-05	0.000268	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	7.13e-05	0.000266	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	7.12e-05	0.000266	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—pancreatic cancer	6.99e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	6.98e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	6.98e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	6.97e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	6.96e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—pancreatic cancer	6.93e-05	0.000258	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	6.82e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	6.82e-05	0.000254	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCND1—pancreatic cancer	6.74e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.7e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	6.68e-05	0.000249	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CTNNB1—pancreatic cancer	6.68e-05	0.000249	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—pancreatic cancer	6.59e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—pancreatic cancer	6.55e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—pancreatic cancer	6.51e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	6.5e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	6.49e-05	0.000242	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	6.43e-05	0.00024	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	6.43e-05	0.00024	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—pancreatic cancer	6.37e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	6.35e-05	0.000237	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HES1—pancreatic cancer	6.35e-05	0.000237	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—pancreatic cancer	6.35e-05	0.000237	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	6.29e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	6.28e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	6.28e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	6.21e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	6.15e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	6.15e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	6.08e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	6.08e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—pancreatic cancer	6.03e-05	0.000225	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—pancreatic cancer	5.88e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	5.84e-05	0.000218	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—pancreatic cancer	5.82e-05	0.000217	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NRAS—pancreatic cancer	5.81e-05	0.000217	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CD—pancreatic cancer	5.8e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	5.73e-05	0.000214	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	5.61e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TERT—pancreatic cancer	5.56e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	5.52e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.47e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	5.41e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	5.41e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—pancreatic cancer	5.41e-05	0.000202	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—pancreatic cancer	5.39e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.36e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	5.32e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	5.31e-05	0.000198	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	5.3e-05	0.000198	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—pancreatic cancer	5.29e-05	0.000197	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—pancreatic cancer	5.19e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—pancreatic cancer	5.09e-05	0.00019	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CB—pancreatic cancer	5.05e-05	0.000189	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—pancreatic cancer	5.01e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KRAS—pancreatic cancer	5e-05	0.000186	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	4.97e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	4.87e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	4.84e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	4.82e-05	0.00018	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	4.79e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	4.72e-05	0.000176	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	4.69e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	4.69e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGF—pancreatic cancer	4.63e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	4.63e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	4.6e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—pancreatic cancer	4.59e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	4.53e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	4.5e-05	0.000168	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	4.47e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—pancreatic cancer	4.44e-05	0.000166	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	4.43e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	4.38e-05	0.000163	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—pancreatic cancer	4.37e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	4.34e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	4.31e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	4.27e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	4.27e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRAS—pancreatic cancer	4.25e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	4.22e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	4.19e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	4.18e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	4.16e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	4.12e-05	0.000154	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	4.1e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.08e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	4.07e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	4.06e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	4.03e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	3.97e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	3.86e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	3.78e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	3.76e-05	0.00014	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—pancreatic cancer	3.75e-05	0.00014	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	3.72e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	3.71e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	3.71e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	3.68e-05	0.000137	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	3.64e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	3.64e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	3.59e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	3.46e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	3.45e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	3.45e-05	0.000129	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	3.43e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	3.39e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	3.38e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	3.38e-05	0.000126	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	3.33e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	3.31e-05	0.000124	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	3.3e-05	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	3.22e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	3.2e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.18e-05	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	3.13e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	3.12e-05	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	3.1e-05	0.000116	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—pancreatic cancer	3.08e-05	0.000115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	3.03e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.94e-05	0.00011	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—pancreatic cancer	2.88e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.87e-05	0.000107	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	2.84e-05	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	2.8e-05	0.000105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	2.78e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	2.78e-05	0.000104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	2.77e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	2.72e-05	0.000101	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	2.66e-05	9.92e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—pancreatic cancer	2.58e-05	9.63e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	2.57e-05	9.6e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	2.52e-05	9.41e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—pancreatic cancer	2.52e-05	9.39e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	2.4e-05	8.95e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	2.38e-05	8.89e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	2.35e-05	8.76e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.19e-05	8.17e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.12e-05	7.9e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.03e-05	7.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.79e-05	6.68e-05	CbGpPWpGaD
